Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Tom Fahey a Tayside Centre for General Practice,
University of Dundee, Dundee DD2 4AD, b Division of
Primary Health Care, University of Bristol, Bristol BS6 6JL, c Bradgate Surgery, Bristol BS10 6SP, d National Primary Care
Research and Development Centre, University of Manchester, Manchester
M13 6PL Correspondence to: T Fahey
t.p.fahey{at}dundee.ac.uk
| |
Abstract |
|---|
|
|
|---|
Objectives:
To assess the quality of care given to
elderly people and compare the care given to residents in nursing homes with those living in their own homes.
Design:
Controlled observational study.
Setting:
Primary care, Bristol.
Subjects:
Elderly individuals (aged
65 years)
registered with three general practices, of whom 172 were residents in
nursing homes (cases) and 526 lived at home (matched controls).
Main outcome measures:
The quality of clinical care
given to patients was measured against explicit standards. Quality
indicators were derived from national sources and agreed with
participating general practitioners.
Results:
The overall standard of care was inadequate when judged against the quality indicators, irrespective of where patients lived. The overall prescribing of beneficial drugs for some
conditions was deficient
for example, only 38% (11/29) (95% confidence interval 20% to 58%) of patients were prescribed
blockers after myocardial infarction. The proportion of patients with
heart disease or diabetes who had had their blood pressure measured in
the past two years (heart disease) or past year (diabetes) was lower
among those living in nursing homes: for heart disease, 74% (17/23)
v 96% (122/127) (adjusted odds ratio 0.18, 0.04 to 0.75);
for diabetes, 62% (8/13) v 96% (50/52) (adjusted odds
ratio 0.05, 0.01 to 0.38). In terms of potentially harmful prescribing, significantly more patients in nursing homes were prescribed
neuroleptic medication (28% (49/172) v 11% (56/526) (3.82, 2.37 to 6.17)) and laxatives (39% (67/172) v 16% (85/526)
(2.79, 1.79 to 4.36)). Nursing home residents were less likely to have
the appropriate diagnostic Read code linked to their prescribed
neuroleptic drug (0.22, 0.07 to 0.71).
Conclusions:
The quality of medical care that elderly
patients receive in one UK city, particularly those in nursing homes,
is inadequate. We suggest that better coordinated care for these patients would avoid the problems of overuse of unnecessary or harmful
drugs, underuse of beneficial drugs, and poor monitoring of chronic disease.
|
What is already known on this topic
The quality of medical care for those living in nursing and residential homes has also been questioned What this study adds
Those living in nursing homes receive poorer care than those living at home in terms of underuse of beneficial drugs, poor monitoring of chronic disease, and overuse of inappropriate or unnecessary drugs |
| |
Introduction |
|---|
|
|
|---|
Concern has been expressed about the quality of medical care that elderly residents receive in residential and nursing homes.1 General practitioners are responsible for the delivery of such care to residents in these homes. The number of elderly patients living in nursing homes rose substantially in the late 1980s and in the 1990s, resulting in a rise in workload for general practitioners. 1 2 Concern has been expressed that the reduction in provision of long stay NHS beds for elderly people has increased the demand on general practitioners in this group of patients with high morbidity and disability. 1 2 In response to these increasing demands, the arrangements made by general practices for delivering care to nursing homes seems to be inconsistent and idiosyncratic.3
More widespread concern has been expressed about drug treatment in elderly people.4 Anxiety about the risks of excessive prescribing of, for example, inappropriate neuroleptic drugs,5 is matched by concern about the consequences of the underprescribing of potentially beneficial drugs.4
Care of elderly people is now a national priority,6
and the quality of care delivered to patients is coming under
increasing scrutiny through the use of explicit measures
"quality
indicators"
which seek to judge the process of care against specific
standards.
7 8
No study has examined the overall quality
of care given to elderly patients in UK primary care or has judged the
quality of care against agreed, explicit standards in patients living
in nursing homes compared with patients living at home. We aimed to
evaluate one dimension of quality
clinical care given to
patients.9 We measured the following components of poor
clinical care: insufficient use of beneficial drugs; poor monitoring of
chronic disease; and overuse of inappropriate or unnecessary
drugs.9 The clinical care given to a sample of elderly
patients living in nursing homes (cases) was compared with the clinical
care given to elderly people living in their own homes (controls).
| |
Methods |
|---|
|
|
|---|
Subjects
Three general practices with registered patients resident in four
Bristol nursing homes agreed to participate in the study. TF provided
care at one of these practices. All nursing home residents aged 65 years or over were identified from each practice's computerised list.
In each practice, we randomly selected four patients who lived in their
own homes to act as controls for each nursing home resident,
stratifying by sex and age in 10-year bands. For strata with fewer than
four controls per nursing home resident, we included all available
control patients. We excluded patients with terminal illness.
Generation of quality indicators
We measured the quality of care with the "explicit process
criteria" method,8 measuring the care given to patients against explicit quality standards or indicators. The quality indicators were derived mostly from a recognised and recently published
textbook.7 We selected the quality indicators on the basis
of their relevance to general practice, and care of elderly patients in
particular. We advised the general practitioners responsible for
delivering nursing home care in each of the three practices about the
provisional set of quality indicators and gave them the relevant source
of information to back up each quality indicator. We discussed and
agreed with the general practitioners a set of quality indicators
before starting the study (box).
|
List of quality indicators used as basis for outcome
measurements in the study
|
Data collection
All the practices in the study use computer and paper patient
records. We examined both formats for every patient. Data were
extracted by JP or JB using a computerised data collection form. The
following data were collected: Read code and diagnosis of up to 10 current problems; up to 15 currently prescribed drugs; influenza and
pneumococcal immunisation, with date measured if the patient was
diabetic; record of HbA1c concentration if the patient was
diabetic; blood pressure record if the patient had coronary artery
disease, hypertension, or diabetes; and contraindications to aspirin or
blockers. Data were collected from November 2001 to February 2002.
Sample size
The primary outcome for the study was a documented record that the
patient had either received vaccination against influenza since
September 2001 or been offered the vaccine and refused. Unpublished
data from the Somerset morbidity survey (R Martin, personal
communication) showed that half of patients aged 65 or over would have
received or been offered influenza vaccination in the winter of
1999-2000. To detect a difference of 13.5 percentage points in uptake
or offer of vaccination (equivalent to an odds ratio of either 0.6 or
1.7), with 80% power, two sided 5%
, and a ratio of four community
controls to every nursing home resident, we needed a total sample size
of 695 patients.
Statistical analysis
Associations between residence (nursing home versus living at
home) and the presence of quality indicators in patients' notes were
investigated by using odds ratios. Using logistic regression, we
adjusted crude odds ratios for age, sex, practice, and overall
morbidity (indicated by the number of current problems and current drug
treatment). All analyses were done with STATA software, version 7.0.
| |
Results |
|---|
|
|
|---|
We identified 172 nursing home residents and 526 controls from the three practices. Among those aged 80 years or over, fewer than four controls per nursing home resident were available, so all controls were included. Nursing home residents were older and had slightly fewer current diagnosed problems but were prescribed more drugs (table 1).
|
Of the 698 patients, 162 did not have any record of having either received or been offered influenza vaccination for the current winter. The likelihood of receiving influenza vaccination was not associated with place of residence (adjusted odds ratio 0.81, 95% confidence interval 0.53 to 1.26) (table 2).
|
Frequency of blood pressure measurement was poorer among nursing home
residents than controls. Among patients with coronary artery disease,
74% (17/23) of nursing home residents (compared with 96% (122/127) of
controls) had had their blood pressure measured in the past two years
(0.18, 0.04 to 0.75) (table 2). There were no differences between the
groups for prescribing of either aspirin or
blockers. Among
patients with hypertension, 53% (18/34) of nursing home residents
(compared with 85% (174/204) of controls) had had their blood pressure
measured in the past year (0.20, 0.09 to 0.47) (table 2). However,
among patients with hypertension who had had their blood pressure
measured in the past year, a higher proportion of nursing home
residents (61% (11/18)) than of controls (46% (82/180)) had blood
pressure <150/90 mm Hg (2.56, 0.88 to 7.47, although this result was
of only borderline significance (table 2).
In diabetic patients, recording of HbA1c concentration was worse in the nursing home residents (54% (7/13)) than in the controls (85% (44/52)) (0.25, 0.06 to 1.13), although this result was again of borderline significance; recording of blood pressure was also worse (62% (8/13) v 96% (50/52)) (0.05, 0.01 to 0.38). However, mean (SD) HbA1c concentrations in nursing home residents and controls (0.08 (0.02) v 0.08 (0.01) respectively; P=0.71) were similar, as were the proportions of patients with blood pressure <140/80 mm Hg (table 2). Nursing home residents were less likely than controls to have received or been offered pneumococcal vaccination (0.15, 0.03 to 0.70), but the proportions of patients offered flu vaccine were similar (table 2).
Over a quarter (28% (49/172)) of nursing home residents were taking neuroleptic drugs, a significantly higher proportion than in the controls (11% (56/526); 3.82, 2.37 to 6.17). For patients taking neuroleptic medication, patient records were more likely to contain the appropriate diagnostic Read code if the patients were living at home (91% (51/56) v 67% (33/49) (table 2). Only 10 patients in the whole study were currently being prescribed thioridazine, all of whom were nursing home residents.
Overall, about two fifths (39% (67/172)) of nursing home
residents were currently prescribed a laxative, a significantly higher proportion than in the controls (16% (85/526); 2.79, 1.79 to 4.36). For patients prescribed a laxative, there was no difference in the
recording of the appropriate Read code between the nursing home
residents and those living at home (table 2).
| |
Discussion |
|---|
|
|
|---|
The results of this study suggest that elderly people in one UK city are receiving inadequate care. Inadequate care takes several different forms: insufficient use of beneficial drugs; poor monitoring of chronic disease; and overuse of inappropriate or unnecessary drugs. 4 10 We have shown that poor monitoring of disease and unnecessary drug prescribing are more likely to occur in nursing home residents than in people living at home, even after comorbidity and amount of prescribed medication are controlled for. These findings are particularly topical in the light of government policy that aims to improve health care for older people. 6 11-13
Context of other studies
In terms of prescribing beneficial treatment, the low level (38%
(95% confidence interval 20% to 58%)) of
blocker prescribing in
patients with a history of myocardial infarction is consistent with
other studies in the United Kingdom and United States.14-16 Overall use of
blockers was reported to
be higher in a US survey, with half of patients nationally taking
blockers after discharge from hospital, but with substantial variation in different states (range 30% to 77%).14 In the United
Kingdom two recent randomised trials have shown a similarly low level of
blocker prescribing in patients who had had a myocardial infarction.
15 16
Data on secondary prevention in European
countries from the EUROASPIRE Group show greater use of
blockers,
but these data may not be directly comparable as the study took place in a younger population of patients.17
In contrast, the overall prescribing of aspirin in coronary heart disease (61%) was lower than in some reports of clinical practice in the United Kingdom (reported to be in the range of 80-90%), 15 18 but not in others.16 In terms of the process of care for chronic disease, nursing home residents fared worse than their counterparts living at home for monitoring both of blood pressure and HbA1c concentration, though the nursing home patients whose blood pressure was recorded seemed to have better control. A previous report highlighted that the level of macrovascular complications was greater in nursing home residents with diabetes than in controls living at home.19 As the interval between the key process of care and the outcome of macrovascular complications is long, it was not possible in this study to attribute poor outcome to recent clinical care.8 This study provides evidence that nursing home residents with diabetes receive poorer care in terms of selected preventive and management interventions.
Our study has also confirmed suggestions of inappropriate drug use in elderly people, particularly those in nursing homes.4 The overall level of prescribing of neuroleptic drugs in nursing home residents (28%) was higher than levels reported in a previous survey among nursing home residents in Glasgow.5 Use of thioridazine was low, but all the patients who had been prescribed this drug were nursing home residents. Among patients receiving neuroleptic drugs, patient records were less likely to contain the appropriate diagnostic Read code if the patients were living in a nursing home. Lastly, nursing home residents were almost three times as likely to receive a laxative as those living at home. Added to the fact that nursing home residents received on average more drug treatment than those living at home, concerns about overprescription of inappropriate drugs (with the attendant dangers of iatrogenic side effects and "prescribing cascades") seem more likely in relation to nursing home residents.20
Study limitations
We did not measure other important dimensions of quality, such as
access to care and how well health professionals relate to patients,
particularly in terms of continuity of care.9 We did not
examine the temporal relation between the process of care, comorbidity,
and prescribing of drugs and did not control for the number of visits
to the surgery or home visits to patients. We did not measure how
recently a patient had been discharged from hospital, so a proportion
of the prescribing in this study could be attributable to hospital
doctors rather than general practitioners. A qualitative study design
would be more appropriate for exploring elderly patients' (and their
carers') expectations of care. Elderly people often have several
chronic diseases and may prefer to have less suffering and an improved
quality of life rather than treatment for every disease they
have.
4 21
Lastly, the findings of this study need to be
reproduced in a larger sample of practices, with follow up of patients,
so that the outcome of clinical care can be assessed.
Future research
Future studies should continue to focus on the quality of care
that elderly patients receive, in terms of clinical care, access to
care, and the doctor-patient relationship.9 Interventions
designed to improve the care of elderly patients in institutions should
reflect and assess the different ways in which general practitioners,
specialists, and nurses deliver this care.1 Educational
interventions aimed at medical staff can have a substantial impact on
the prescribing of neuroleptic drugs in patients in nursing
homes.22 Other dimensions of care, aside from the
prescribing of drugs, are equally relevant to elderly patients. For
example, the continuous assessment review and evaluation (CARE) scheme,
which focuses on incontinence, management of decubital ulcers, autonomy
of the patient, and drug use.22 Lastly, assessment of
quality of care should consider the preferences of patients and their
carers for drug treatments in terms of both potential benefits21 and potential harm.
20 22
Future
research should combine refinements on better ways to measure the
quality of care with interventions that are designed to improve the
delivery of care to elderly patients.
Conclusion
More sophisticated models of optimal prescribing are needed in
elderly people, with due regard to overuse and underuse of drugs. As
general practitioners provide most medical care to this vulnerable
group, more coordinated models of care are needed to match the needs of
these patients.
| |
Acknowledgments |
|---|
We particularly thank the participating general practitioners and nursing home staff. We also thank Ray Sheridan for help with data collection and Alastair Hay, Chris Salisbury, Frank Sullivan, Tim Peters, and Marjorie Weiss for helpful comments about the study.
Contributors: TF generated the idea, wrote the study protocol, and supervised data collection. JB and JP collected the data. AAM analysed the data with input from TF. All authors contributed to the writing of the study. TF will act as guarantor.
| |
Footnotes |
|---|
Funding: This study was funded through an extended registrar contract for JB and through additional research funding from an NHS R&D primary care career scientist award for TF. The guarantor accepts full responsibility for the conduct of the study, had access to the data, and controlled the decision to publish.
Competing interest: None declared.
Ethical approval: Ethical approval for the study was obtained
from the local research ethics committee.
| |
References |
|---|
|
|
|---|
| 1. |
Black D, Bowman C.
Community institutional care for frail elderly people.
BMJ
1997;
315:
441-442 |
| 2. |
Kavanagh S, Knapp M.
The impact on general practitioners of the changing balance of care for elderly people living in institutions.
BMJ
1998;
317:
322-327 |
| 3. |
Kavanagh S, Knapp M.
Primary care arrangements for elderly people in residential and nursing homes.
BMJ
1999;
318:
666 |
| 4. |
Rochon P, Gurwitz JH.
Prescribing for seniors. Neither too much nor too little.
JAMA
1999;
282:
113-115 |
| 5. |
McGrath A, Jackson G.
Survey of neuroleptic prescribing in residents of nursing homes in Glasgow.
BMJ
1996;
312:
611-612 |
| 6. | Department of Health. National service framework for older people. London: DoH, 2001. |
| 7. | Marshall M, Campbell C, Hacker J, Roland M, eds. Quality indicators in general practice. London: Royal Society of Medicine Press, 2001. |
| 8. |
Brook RH, McGlynn EA, Cleary PD.
Quality of health care. Part 2: measuring quality of care.
N Engl J Med
1996;
335:
966-970 |
| 9. | Roland M. Quality and efficiency: enemies or partners? Br J Gen Pract 1999; 49: 140-143[Medline]. |
| 10. |
Gurwitz JH, Rochon P.
Improving the quality of medication use in elderly patients.
Arch Intern Med
2002;
162:
1670-1672 |
| 11. | Expert Group on Healthcare of Older People. Adding life to years. Glasgow: Scottish Executive, 2002. |
| 12. |
Rochon PA, Bronskill SE, Gurwitz JH.
Health care for older people.
BMJ
2002;
324:
1231-1232 |
| 13. | Improving the quality of long-term care. Washington, DC: National Academy Press, 2001. |
| 14. |
Krumholz HM, Radford MJ, Wang Y, Chen J, Heiat A, Marciniak TA.
National use and effectiveness of beta-blockers for the treatment of elderly patients after acute myocardial infarction: national cooperative cardiovascular project.
JAMA
1998;
280:
623-629 |
| 15. |
Feder G, Griffiths C, Eldridge S, Spence M.
Effect of postal prompts to patients and general practitioners on the quality of primary care after a coronary event (POST): randomised controlled trial.
BMJ
1999;
318:
1522-1526 |
| 16. |
Campbell NC, Thain J, Deans HG, Ritchie LD, Rawles JM.
Secondary prevention in coronary heart disease: baseline survey of provision in general practice.
BMJ
1998;
316:
1430-1434 |
| 17. | EUROASPIRE 1 and 11 Group. Clinical reality of coronary prevention guidelines: a comparison of EUROASPIRE 1 and 11 in nine countries. Lancet 2001; 357: 995-1001[CrossRef][Web of Science][Medline]. |
| 18. |
Jolly K, Bradley F, Sharp S, Smith H, Thompson S, Kinmonth AL, et al.
Randomised controlled trial of follow up care in general practice of patients with myocardial infarction and angina: final results of the Southampton heart integrated care project (SHIP).
BMJ
1999;
318:
706-711 |
| 19. |
Benbow S, Walsh A, Gill G.
Diabetes in institutionalised elderly people: a forgotton population?
BMJ
1997;
314:
1868 |
| 20. |
Rochon PA, Gurwitz JH.
Optimising drug treatment for elderly people: the prescribing cascade.
BMJ
1997;
315:
1096-1099 |
| 21. |
Redelmeier DA, Tan SH, Booth GL.
The treatment of unrelated disorders in patients with chronic medical diseases.
N Engl J Med
1998;
338:
1516-1520 |
| 22. |
Wagner C, van der Wal G, Groenewegen PP, de Bakker DH.
The effectiveness of quality systems in nursing homes: a review.
Quality and Safety in Health Care
2001;
10:
211-217 |
| 23. | Committee on Safety of Medicines. Thioridazine: restricted indications and new warnings on cardiotoxicity. London: Medicines Control Agency, 2000. |
| 24. | Gurvich T, Cunningham JA. Appropriate use of psychotropic drugs in nursing homes. Am Fam Physician 2000; 61: 1437-1446[Medline]. |
| 25. | National Prescribing Centre. The management of constipation. MeReC Bull 1999;10. |
(Accepted 21 January 2003)
Read all Rapid Responses